KORU Medical Systems, Inc. (KRMD)
USD 2.32
(1.75%)
USD 2.32
(1.75%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -7.03 Million USD | 43.63% |
| 2022 | -12.48 Million USD | 49.52% |
| 2021 | -24.73 Million USD | 8.66% |
| 2020 | -27.07 Million USD | -393.25% |
| 2019 | -5.48 Million USD | -46.82% |
| 2018 | -3.73 Million USD | 5.93% |
| 2017 | -3.97 Million USD | -19.96% |
| 2016 | -3.31 Million USD | 21.15% |
| 2015 | -4.2 Million USD | -64.32% |
| 2014 | -2.55 Million USD | -14.81% |
| 2013 | -2.22 Million USD | -49.39% |
| 2012 | -1.49 Million USD | -17.0% |
| 2011 | -1.27 Million USD | 3.22% |
| 2010 | -1.31 Million USD | -966.93% |
| 2009 | -123.41 Thousand USD | -143.19% |
| 2008 | 285.77 Thousand USD | -61.9% |
| 2007 | 749.98 Thousand USD | -9.36% |
| 2006 | 827.47 Thousand USD | 15.14% |
| 2005 | 718.68 Thousand USD | 10.96% |
| 2004 | 647.68 Thousand USD | 70.52% |
| 2003 | 379.82 Thousand USD | 12.1% |
| 2002 | 338.82 Thousand USD | 5.86% |
| 2001 | 320.07 Thousand USD | 347.26% |
| 2000 | 71.56 Thousand USD | 142.83% |
| 1999 | -167.08 Thousand USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | -6.49 Million USD | 2.35% |
| 2024 Q1 | -6.64 Million USD | 5.53% |
| 2023 Q1 | -7.62 Million USD | 38.93% |
| 2023 Q3 | -6.14 Million USD | 17.48% |
| 2023 Q2 | -7.44 Million USD | 2.32% |
| 2023 FY | -7.03 Million USD | 43.63% |
| 2023 Q4 | -7.03 Million USD | -14.5% |
| 2022 Q3 | -11.38 Million USD | 17.07% |
| 2022 FY | -12.48 Million USD | 49.52% |
| 2022 Q4 | -12.48 Million USD | -9.66% |
| 2022 Q1 | -18.01 Million USD | 27.17% |
| 2022 Q2 | -13.72 Million USD | 23.8% |
| 2021 Q1 | -26.57 Million USD | 1.86% |
| 2021 Q2 | -26.37 Million USD | 0.75% |
| 2021 Q4 | -24.73 Million USD | 2.74% |
| 2021 Q3 | -25.42 Million USD | 3.57% |
| 2021 FY | -24.73 Million USD | 8.66% |
| 2020 Q3 | -32.15 Million USD | 6.29% |
| 2020 Q2 | -34.31 Million USD | -514.87% |
| 2020 Q4 | -27.07 Million USD | 15.81% |
| 2020 FY | -27.07 Million USD | -393.25% |
| 2020 Q1 | -5.58 Million USD | -1.68% |
| 2019 Q1 | -2.11 Million USD | 43.42% |
| 2019 Q3 | -4.71 Million USD | -40.31% |
| 2019 Q4 | -5.48 Million USD | -16.33% |
| 2019 FY | -5.48 Million USD | -46.82% |
| 2019 Q2 | -3.36 Million USD | -58.99% |
| 2018 Q1 | -4.03 Million USD | -1.47% |
| 2018 FY | -3.73 Million USD | 5.93% |
| 2018 Q2 | -3.42 Million USD | 15.17% |
| 2018 Q4 | -3.73 Million USD | -2.45% |
| 2018 Q3 | -3.64 Million USD | -6.67% |
| 2017 Q2 | -2.98 Million USD | 9.98% |
| 2017 Q1 | -3.31 Million USD | 3.69% |
| 2017 FY | -3.97 Million USD | -19.96% |
| 2017 Q4 | -3.97 Million USD | -8.54% |
| 2017 Q3 | -3.66 Million USD | -22.77% |
| 2016 Q2 | -3.86 Million USD | 8.12% |
| 2016 FY | -3.31 Million USD | 21.15% |
| 2016 Q3 | -3.96 Million USD | -2.73% |
| 2016 Q1 | -4.2 Million USD | -25.82% |
| 2016 Q4 | -3.44 Million USD | 13.26% |
| 2015 Q2 | -2.47 Million USD | 3.39% |
| 2015 Q1 | -2.55 Million USD | -13.76% |
| 2015 Q4 | -3.33 Million USD | -5.78% |
| 2015 Q3 | -3.15 Million USD | -27.78% |
| 2015 FY | -4.2 Million USD | -64.32% |
| 2014 Q3 | -2.24 Million USD | 4.13% |
| 2014 Q4 | -2.24 Million USD | -0.25% |
| 2014 Q2 | -2.33 Million USD | -5.0% |
| 2014 FY | -2.55 Million USD | -14.81% |
| 2014 Q1 | -2.22 Million USD | -15.92% |
| 2013 FY | -2.22 Million USD | -49.39% |
| 2013 Q4 | -1.92 Million USD | -4.74% |
| 2013 Q3 | -1.83 Million USD | -12.32% |
| 2013 Q2 | -1.63 Million USD | -9.54% |
| 2013 Q1 | -1.49 Million USD | 11.27% |
| 2012 Q1 | -1.27 Million USD | 3.91% |
| 2012 Q3 | -1.93 Million USD | -28.24% |
| 2012 FY | -1.49 Million USD | -17.0% |
| 2012 Q2 | -1.51 Million USD | -18.53% |
| 2012 Q4 | -1.68 Million USD | 13.26% |
| 2011 Q4 | -1.32 Million USD | 2.31% |
| 2011 FY | -1.27 Million USD | 3.22% |
| 2011 Q2 | -1.26 Million USD | 3.85% |
| 2011 Q1 | -1.31 Million USD | -58.78% |
| 2011 Q3 | -1.35 Million USD | -7.23% |
| 2010 Q1 | -123.41 Thousand USD | -200.3% |
| 2010 FY | -1.31 Million USD | -966.93% |
| 2010 Q4 | -829.31 Thousand USD | -72.95% |
| 2010 Q3 | -479.52 Thousand USD | -19.41% |
| 2010 Q2 | -401.55 Thousand USD | -225.37% |
| 2009 Q3 | 207.87 Thousand USD | -2.92% |
| 2009 Q4 | 123.04 Thousand USD | -40.81% |
| 2009 FY | -123.41 Thousand USD | -143.19% |
| 2009 Q1 | 285.77 Thousand USD | -37.6% |
| 2009 Q2 | 214.12 Thousand USD | -25.07% |
| 2008 Q3 | 685.93 Thousand USD | -3.33% |
| 2008 FY | 285.77 Thousand USD | -61.9% |
| 2008 Q4 | 457.95 Thousand USD | -33.24% |
| 2008 Q2 | 709.56 Thousand USD | -5.39% |
| 2008 Q1 | 749.98 Thousand USD | -13.6% |
| 2007 FY | 749.98 Thousand USD | -9.36% |
| 2007 Q4 | 868.01 Thousand USD | 1.76% |
| 2007 Q3 | 852.98 Thousand USD | 1.72% |
| 2007 Q2 | 838.56 Thousand USD | 1.34% |
| 2007 Q1 | 827.47 Thousand USD | -1.71% |
| 2006 Q4 | 841.84 Thousand USD | 0.97% |
| 2006 Q1 | 718.68 Thousand USD | 5.61% |
| 2006 FY | 827.47 Thousand USD | 15.14% |
| 2006 Q2 | 786.2 Thousand USD | 9.4% |
| 2006 Q3 | 833.75 Thousand USD | 6.05% |
| 2005 Q3 | 725.59 Thousand USD | -1.93% |
| 2005 Q2 | 739.89 Thousand USD | 14.24% |
| 2005 Q1 | 647.68 Thousand USD | 5.38% |
| 2005 Q4 | 680.49 Thousand USD | -6.21% |
| 2005 FY | 718.68 Thousand USD | 10.96% |
| 2004 Q2 | 471.87 Thousand USD | 24.24% |
| 2004 Q1 | 379.82 Thousand USD | 0.41% |
| 2004 FY | 647.68 Thousand USD | 70.52% |
| 2004 Q4 | 614.61 Thousand USD | 10.64% |
| 2004 Q3 | 555.49 Thousand USD | 17.72% |
| 2003 Q2 | 352.23 Thousand USD | 3.96% |
| 2003 Q1 | 338.82 Thousand USD | 10.18% |
| 2003 Q4 | 378.25 Thousand USD | 10.5% |
| 2003 Q3 | 342.3 Thousand USD | -2.82% |
| 2003 FY | 379.82 Thousand USD | 12.1% |
| 2002 Q1 | 320.07 Thousand USD | 31.6% |
| 2002 Q2 | 323.38 Thousand USD | 1.03% |
| 2002 Q3 | 251.16 Thousand USD | -22.33% |
| 2002 Q4 | 307.52 Thousand USD | 22.44% |
| 2002 FY | 338.82 Thousand USD | 5.86% |
| 2001 Q2 | 156.02 Thousand USD | 118.02% |
| 2001 Q3 | 200.45 Thousand USD | 28.48% |
| 2001 Q4 | 243.22 Thousand USD | 21.34% |
| 2001 Q1 | 71.56 Thousand USD | 13.42% |
| 2001 FY | 320.07 Thousand USD | 347.26% |
| 2000 Q4 | 63.09 Thousand USD | 153.62% |
| 2000 FY | 71.56 Thousand USD | 142.83% |
| 2000 Q2 | -136.11 Thousand USD | 0.0% |
| 2000 Q3 | -117.66 Thousand USD | 13.55% |
| 1999 FY | -167.08 Thousand USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Akoya Biosciences, Inc. | 2.58 Million USD | 372.651% |
| AngioDynamics, Inc. | -70.14 Million USD | 89.967% |
| AtriCure, Inc. | -9.81 Million USD | 28.31% |
| Avinger, Inc. | 10.12 Million USD | 169.537% |
| Azenta, Inc. | -618.47 Million USD | 98.862% |
| BioLife Solutions, Inc. | 7.25 Million USD | 197.024% |
| The Cooper Companies, Inc. | 2.44 Billion USD | 100.287% |
| Daxor Corporation | 755.65 Thousand USD | 1031.256% |
| Ekso Bionics Holdings, Inc. | -1.47 Million USD | -378.716% |
| Femasys Inc. | -15.01 Million USD | 53.133% |
| GlucoTrack, Inc. | -4.29 Million USD | -63.806% |
| Harvard Bioscience, Inc. | 38.49 Million USD | 118.283% |
| Hologic, Inc. | 374.4 Million USD | 101.88% |
| ICU Medical, Inc. | 1.45 Billion USD | 100.485% |
| Intuitive Surgical, Inc. | -2.66 Billion USD | 99.735% |
| LeMaitre Vascular, Inc. | -5.17 Million USD | -36.009% |
| Innovative Eyewear, Inc. | -4.28 Million USD | -64.133% |
| Innovative Eyewear, Inc. | -4.28 Million USD | -64.133% |
| Masimo Corporation | 804 Million USD | 100.875% |
| Microbot Medical Inc. | -2.28 Million USD | -207.836% |
| Meihua International Medical Technologies Co., Ltd. | -9.59 Million USD | 26.664% |
| Merit Medical Systems, Inc. | 302.22 Million USD | 102.328% |
| Nephros, Inc. | -2.47 Million USD | -184.788% |
| NovoCure Limited | 355.42 Million USD | 101.98% |
| NEXGEL, Inc. | 98 Thousand USD | 7280.735% |
| NEXGEL, Inc. | 98 Thousand USD | 7280.735% |
| Singular Genomics Systems, Inc. | 59.05 Million USD | 111.916% |
| OraSure Technologies, Inc. | -276.9 Million USD | 97.459% |
| Pro-Dex, Inc. | 10.91 Million USD | 164.466% |
| Pulse Biosciences, Inc. | -35.22 Million USD | 80.02% |
| Predictive Oncology Inc. | -5.87 Million USD | -19.845% |
| Precision Optics Corporation, Inc. | 3.02 Million USD | 332.311% |
| QuidelOrtho Corporation | 2.49 Billion USD | 100.282% |
| Repligen Corporation | -39.51 Million USD | 82.193% |
| Sanara MedTech Inc. | 6.64 Million USD | 205.903% |
| STAAR Surgical Company | -147.2 Million USD | 95.219% |
| Sharps Technology, Inc. | -3.01 Million USD | -133.566% |
| Utah Medical Products, Inc. | -92.52 Million USD | 92.394% |
| DENTSPLY SIRONA Inc. | 1.96 Billion USD | 100.358% |
| Jin Medical International Ltd. | -2.81 Million USD | -149.853% |